1. Home
  2. CUBI vs BEAM Comparison

CUBI vs BEAM Comparison

Compare CUBI & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Customers Bancorp Inc

CUBI

Customers Bancorp Inc

N/A

Current Price

$79.50

Market Cap

2.8B

Sector

Finance

ML Signal

N/A

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

N/A

Current Price

$20.92

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CUBI
BEAM
Founded
1994
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.8B
IPO Year
2010
2019

Fundamental Metrics

Financial Performance
Metric
CUBI
BEAM
Price
$79.50
$20.92
Analyst Decision
Buy
Strong Buy
Analyst Count
11
15
Target Price
★ $100.09
$49.85
AVG Volume (30 Days)
268.5K
★ 2.1M
Earning Date
10-22-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
22.99
★ 82.31
EPS
★ 6.28
N/A
Revenue
N/A
★ $24,000.00
Revenue This Year
$7.82
N/A
Revenue Next Year
$12.55
N/A
P/E Ratio
$12.82
★ N/A
Revenue Growth
N/A
★ 33.33
52 Week Low
$64.08
$20.44
52 Week High
$89.60
$38.26

Technical Indicators

Market Signals
Indicator
CUBI
BEAM
Relative Strength Index (RSI) 39.33 35.27
Support Level $72.86 N/A
Resistance Level $79.93 $27.30
Average True Range (ATR) 2.26 1.72
MACD -0.92 -0.61
Stochastic Oscillator 1.30 3.31

Price Performance

Historical Comparison
CUBI
BEAM

About CUBI Customers Bancorp Inc

Customers Bancorp Inc is a bank holding company conducting banking activities through its wholly owned subsidiary, Customers Bank. The Bank provides commercial and consumer customers the stability of a regulated financial institution supported by risk management. It serves commercial and corporate businesses nationwide, including healthcare, real estate, specialty finance, fund finance, technology and venture capital banking, mortgage finance and commercial equipment financing, and provides payments and treasury services. The Bank also serves consumers through its branch network, offering residential mortgages and personal loan and deposit products, including Banking-as-a-Service, with services delivered predominantly in Southeastern and Central Pennsylvania, New York, and other states.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Share on Social Networks: